)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Stevanato Group
Stevanato Group (STVN) investor relations material
Stevanato Group Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary4 Mar, 2026
Executive summary
Fiscal 2025 delivered 9% constant currency (7% reported) revenue growth, driven by strong execution in high-value solutions (HVS) and Biopharmaceutical and Diagnostic Solutions (BDS), with HVS reaching 46% of total revenue.
GLP-1-related products accounted for 19–20% of total revenue, growing over 50% year-over-year, and are expected to remain a key growth driver.
The company is investing in capacity expansion in Fishers (US) and Latina (Italy) to meet rising demand for high-value syringes and cartridges.
Engineering segment revenue declined, but optimization efforts and growth in pharma visual inspection partially offset the decline.
Gross profit and EBITDA margins expanded, with diluted EPS for FY 2025 up 19% to €0.51 and adjusted diluted EPS up 13% to €0.54.
Financial highlights
Q4 2025 revenue grew 7% at constant currency and 5% reported to €346.5 million; BDS segment up 10%, Engineering down 23%.
Q4 gross profit margin increased 120 bps to 30.9%; Q4 operating profit margin was 20.2%; net profit €47.6 million; adjusted net profit €49.8 million; adjusted diluted EPS €0.18.
Adjusted EBITDA for Q4 rose 7% to €97.7 million, with margin up 70 bps to 28.2%.
FY 2025 net profit was €139.8 million, up 18.7% year-over-year; adjusted EBITDA €298.0 million (25.1% margin).
Full-year CapEx was €294.9 million, with 89% for growth projects; free cash flow improved to €18.4 million.
Outlook and guidance
FY 2026 revenue guidance: €1.26–1.29 billion (reported), or €1.278–1.308 billion (constant currency), with 6–10% growth expected.
Adjusted EBITDA guidance: €331.8–346.9 million; adjusted diluted EPS: €0.59–0.63.
HVS expected to comprise 47–48% of 2026 revenue; BDS segment to grow high single to low double digits, Engineering to decline mid- to low double digits.
CapEx for 2026 forecasted at €270–290 million (gross), €240–260 million (net); free cash flow modeled at breakeven to €20 million.
Management expects continued growth in biologics and improved utilization and efficiencies at new facilities.
How will GLP1 market share evolve in 2026?
Engineering segment turnaround strategy
New facilities margin impact in 2026
GLP-1 market evolution beyond 2026 outlook
Engineering segment order intake recovery plan
Non-GLP biologics growth strategy specifics
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Stevanato Group earnings date
Q1 20267 May, 2026
Stevanato Group
Next Stevanato Group earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Stevanato Group S.p.A. is a global provider of containment, delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries. The company specializes in the production of glass containers, such as vials, syringes, and cartridges, used for drug storage and delivery. In addition to its core manufacturing services, Stevanato offers integrated solutions that include drug delivery systems, assembly equipment, and analytical testing. Its products support a range of applications, including injectable drugs, biologics, and diagnostics, helping ensure the safe and effective administration of treatments. The company is headquartered in Piombino Dese, Italy, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage